ENANTA PHARMACEUTICALS INC (ENTA) Operating income 2016–2025
ENANTA PHARMACEUTICALS INC (ENTA) annual operating income history from SEC filings — each fiscal year as reported.
-$85.3MFY2025 · since FY2016: $30.8M → -$85.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$85.3M | +29.9% |
| FY2024 | -$121.7M | +11.3% |
| FY2023 | -$137.2M | -10.8% |
| FY2022 | -$123.8M | -13.0% |
| FY2021 | -$109.6M | -163.1% |
| FY2020 | -$41.6M | -213.3% |
| FY2019 | $36.7M | -58.4% |
| FY2018 | $88.3M | +258.9% |
| FY2017 | $24.6M | -20.2% |
| FY2016 | $30.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice